LT3749353T - Nemolizumabas atopinio dermatito, pasireiškiančio vidutinio ar didelio laipsnio ekskoriacija, gydymui - Google Patents
Nemolizumabas atopinio dermatito, pasireiškiančio vidutinio ar didelio laipsnio ekskoriacija, gydymuiInfo
- Publication number
- LT3749353T LT3749353T LTEPPCT/IB2019/051051T LTIB2019051051T LT3749353T LT 3749353 T LT3749353 T LT 3749353T LT IB2019051051 T LTIB2019051051 T LT IB2019051051T LT 3749353 T LT3749353 T LT 3749353T
- Authority
- LT
- Lithuania
- Prior art keywords
- nemolizumab
- excoriation
- moderate
- severe
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862628714P | 2018-02-09 | 2018-02-09 | |
| PCT/IB2019/051051 WO2019155427A1 (en) | 2018-02-09 | 2019-02-08 | Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3749353T true LT3749353T (lt) | 2025-09-25 |
Family
ID=65729402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/IB2019/051051T LT3749353T (lt) | 2018-02-09 | 2019-02-08 | Nemolizumabas atopinio dermatito, pasireiškiančio vidutinio ar didelio laipsnio ekskoriacija, gydymui |
Country Status (23)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202535464A (zh) * | 2023-11-02 | 2025-09-16 | 日商丸寶股份有限公司 | 醫藥組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| FR2761994B1 (fr) | 1997-04-11 | 1999-06-18 | Centre Nat Rech Scient | Preparation de recepteurs membranaires a partir de baculovirus extracellulaires |
| DK1188830T3 (da) | 1999-06-02 | 2010-04-26 | Chugai Pharmaceutical Co Ltd | Nyt hæmopoietinreceptorprotein NR10 |
| EP1858924A1 (en) * | 2005-02-14 | 2007-11-28 | ZymoGenetics, Inc. | Methods of treating skin disorders using an il-31ra antagonist |
| JP2010210772A (ja) | 2009-03-13 | 2010-09-24 | Dainippon Screen Mfg Co Ltd | 液晶表示装置の製造方法 |
| CN105859889B (zh) * | 2010-11-17 | 2020-01-07 | 中外制药株式会社 | 具有代替凝血因子viii的功能的功能的多特异性抗原结合分子 |
| US8790651B2 (en) * | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| FI3284480T3 (fi) * | 2015-04-14 | 2025-09-11 | Chugai Pharmaceutical Co Ltd | IL-31-antagonistia vaikuttavana ainesosana sisältävä farmaseuttinen koostumus atooppisen ihottuman ehkäisemiseksi ja/tai hoitamiseksi |
| WO2017093857A1 (en) * | 2015-11-30 | 2017-06-08 | Anacor Pharmaceuticals, Inc. | Topical pharmaceutical formulations for treating inflammatory-related conditions |
-
2019
- 2019-02-08 PL PL19710488.8T patent/PL3749353T3/pl unknown
- 2019-02-08 HR HRP20251101TT patent/HRP20251101T1/hr unknown
- 2019-02-08 FI FIEP19710488.8T patent/FI3749353T3/fi active
- 2019-02-08 SG SG11202007558YA patent/SG11202007558YA/en unknown
- 2019-02-08 MX MX2020008193A patent/MX2020008193A/es unknown
- 2019-02-08 DK DK19710488.8T patent/DK3749353T3/da active
- 2019-02-08 LT LTEPPCT/IB2019/051051T patent/LT3749353T/lt unknown
- 2019-02-08 EP EP25189672.6A patent/EP4644424A3/en active Pending
- 2019-02-08 RU RU2020129578A patent/RU2758378C1/ru active
- 2019-02-08 PT PT197104888T patent/PT3749353T/pt unknown
- 2019-02-08 JP JP2020542801A patent/JP7777921B2/ja active Active
- 2019-02-08 CA CA3090062A patent/CA3090062A1/en active Pending
- 2019-02-08 AU AU2019219608A patent/AU2019219608B2/en active Active
- 2019-02-08 CN CN201980024489.7A patent/CN112040976A/zh active Pending
- 2019-02-08 SI SI201930960T patent/SI3749353T1/sl unknown
- 2019-02-08 ES ES19710488T patent/ES3049513T3/es active Active
- 2019-02-08 EP EP19710488.8A patent/EP3749353B1/en active Active
- 2019-02-08 WO PCT/IB2019/051051 patent/WO2019155427A1/en not_active Ceased
- 2019-02-08 BR BR112020016144-6A patent/BR112020016144A2/pt unknown
- 2019-02-11 TW TW108104519A patent/TWI856006B/zh active
- 2019-02-11 TW TW113115277A patent/TWI923998B/zh active
-
2020
- 2020-08-05 PH PH12020551185A patent/PH12020551185A1/en unknown
- 2020-08-05 IL IL276524A patent/IL276524A/en unknown
- 2020-08-07 US US16/988,554 patent/US12435147B2/en active Active
- 2020-08-07 CL CL2020002050A patent/CL2020002050A1/es unknown
-
2023
- 2023-09-21 JP JP2023155476A patent/JP2023182632A/ja active Pending
-
2025
- 2025-09-11 JP JP2025151311A patent/JP2025176134A/ja active Pending
- 2025-09-12 US US19/327,709 patent/US20260008859A1/en active Pending
-
2026
- 2026-01-13 AU AU2026200182A patent/AU2026200182A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL271085A (en) | Bacteria for the treatment of disorders | |
| HUE064141T2 (hu) | Azolopirimidin rákkal összefüggõ rendellenességek kezelésére | |
| JOP20190194A1 (ar) | مركبات نيوكليوتيدات ثنائية حلقية لعلاج السرطان | |
| EA201891910A1 (ru) | Гетероарильные ингибиторы pad4 | |
| MX2024010175A (es) | Moleculas de anticuerpo contra april y usos de las mismas. | |
| MX378145B (es) | Formulaciones farmacéuticas tópicas que comprenden crisaborol para tratar afecciones inflamatorias | |
| HUE053191T2 (hu) | 2-Heteroaril-3-oxo-2,3-dihidropiridazin-4-karboxamidok rák kezelésére | |
| MX384240B (es) | Bacterias probioticas recombinantes. | |
| EA201891347A1 (ru) | Аза-бензимидазольные ингибиторы pad4 | |
| FR3024465B1 (fr) | Caracterisation de micro-organismes par maldi-tof | |
| PL3609497T3 (pl) | Niraparyb, octan abirateronu i prednizon do leczenia nowotworu złośliwego prostaty | |
| EA201600026A1 (ru) | Бактериальная гиалуронидаза и способ ее производства | |
| MX2024004377A (es) | Tratamiento mejorado de la dermatitis atopica con tradipitant. | |
| PL3978074T3 (pl) | Terlipresyna do leczenia zespołu wątrobowo-nerkowego typu 1 | |
| DK3273797T3 (da) | Sammensætning til at inhibere gram-positive, patogene bakterier | |
| LT3273957T (lt) | Biotinas, skirtas demielinizuojančių neuropatijų gydymui | |
| EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
| LT3554501T (lt) | Deksmedetomidinas arba medetomidinas, skirti naudoti gydant naminių gyvūnų atsiskyrimo nerimą | |
| MX375318B (es) | Formas de dosificación y usos terapéuticos de l-4-cloro quinurenina.. | |
| HUE053089T2 (hu) | Migrén kezelése acetil-leucinnal | |
| LT3519050T (lt) | Kompozicijos, skirtos oftalmologinių būklių gydymui | |
| DK4009942T3 (da) | Forbindelse til kombinationsbehandling | |
| IL268732A (en) | Plant extracts enriched with ipolamiide derivatives as immunosuppressants for treating immunological disorders | |
| DK3749353T3 (da) | Nemolizumab til behandling af atopisk dermatitis med moderat til svær excoriation | |
| MX2020000625A (es) | Metodos para tratar trastornos microvasculares autoinmunes. |